A detailed history of Quent Capital, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Quent Capital, LLC holds 299 shares of ELAN stock, worth $3,552. This represents 0.0% of its overall portfolio holdings.

Number of Shares
299
Previous 299 -0.0%
Holding current value
$3,552
Previous $4,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$14.37 - $16.46 $416 - $477
29 Added 10.74%
299 $4,000
Q4 2023

Jun 14, 2024

BUY
$8.6 - $14.94 $877 - $1,523
102 Added 60.71%
270 $4,000
Q4 2023

Jan 19, 2024

BUY
$8.6 - $14.94 $2,322 - $4,033
270 New
270 $4,000
Q1 2023

Jun 14, 2024

SELL
$8.79 - $14.58 $1,151 - $1,909
-131 Reduced 43.81%
168 $1,000
Q4 2022

Jan 19, 2023

BUY
$11.49 - $13.65 $1,930 - $2,293
168 New
168 $0

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Quent Capital, LLC Portfolio

Follow Quent Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quent Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quent Capital, LLC with notifications on news.